Published in Ir J Med Sci on September 10, 2008
Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob Agents Chemother (1996) 4.41
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation (2002) 3.63
Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother (2009) 3.62
Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA (1996) 3.50
Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet (1995) 2.74
Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect (2010) 2.63
HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. Euro Surveill (2011) 2.42
Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill (2008) 2.13
Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med (1996) 2.08
Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey. Euro Surveill (2009) 1.98
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis (2013) 1.91
Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med (1991) 1.91
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother (2001) 1.74
Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res (1988) 1.71
Central nervous system manifestations of Mycoplasma pneumoniae infections. J Infect (2005) 1.65
Short-term effects of air pollution on mortality in Athens. Int J Epidemiol (1986) 1.61
Antibacterial activity of cinoxacin in vitro. Antimicrob Agents Chemother (1975) 1.50
Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis (2001) 1.42
Community acquired methicillin resistant Staphylococcus aureus pneumonia: an update for the emergency and intensive care physician. Minerva Anestesiol (2012) 1.41
Increased liver decompensation risk with atypical hepatitis C virus antibody levels. J Infect Dis (2000) 1.41
Air pollution and cause specific mortality in Athens. J Epidemiol Community Health (1990) 1.38
Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions. Am J Med (1986) 1.38
Classification of oral cephalosporins. A matter for debate. Int J Antimicrob Agents (2001) 1.38
Sigmoid carcinoma incidentally discovered after perforation caused by an ingested chicken bone. AJR Am J Roentgenol (2001) 1.36
Perforation of the alimentary tract: evaluation with computed tomography. Abdom Imaging (2000) 1.35
First identification of an Escherichia coli clinical isolate producing both metallo-beta-lactamase VIM-2 and extended-spectrum beta-lactamase IBC-1. Clin Microbiol Infect (2004) 1.34
Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin. Biochim Biophys Acta (1989) 1.33
Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res (1990) 1.32
Prevalence of fluoroquinolone resistance in Europe. Study Group 'Bacterial Resistance' of the Paul-Ehrlich-Society for Chemotherapy e. V. Infection (1994) 1.31
A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction (1998) 1.30
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia. The Multicenter Hemophilia Cohort Study. J Infect Dis (1999) 1.27
Dispensing of antibiotics without prescription in Greece, 2008: another link in the antibiotic resistance chain. Euro Surveill (2010) 1.27
Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med (1998) 1.25
School closure is currently the main strategy to mitigate influenza A(H1N1)v: a modeling study. Euro Surveill (2009) 1.24
Increased salivary cortisol reliably induced by a protein-rich midday meal. Psychosom Med (1999) 1.23
A clinical physiologic study of hydroxyethyl starch. Surg Gynecol Obstet (1970) 1.22
Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2. J Viral Hepat (2015) 1.22
Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA. J Virol Methods (2002) 1.20
Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA (1991) 1.20
Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer (1996) 1.18
Antibody responses in early human immunodeficiency virus type 1 infection in hemophiliacs. J Infect Dis (1988) 1.15
Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options. Clin Microbiol Infect (2013) 1.14
Pentoxifylline in the treatment of experimental peritonitis in rats. Arch Surg (1985) 1.14
The validity of gynecological ultrasonography. Gynecol Obstet Invest (1990) 1.12
Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids (1999) 1.10
Detection of aac(6')-I genes in amikacin-resistant Acinetobacter spp. by PCR. Antimicrob Agents Chemother (1994) 1.10
Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients. Clin Microbiol Infect (2011) 1.08
Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat (2006) 1.08
Antipseudomonal antibiotics. Med Clin North Am (2001) 1.07
Periareolar nonpuerperal breast infection: treatment of 38 cases. Clin Infect Dis (1994) 1.07
Effects of lead on the somatic growth of children. Arch Environ Health (1998) 1.06
Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes. Infection (2010) 1.06
In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1984) 1.06
Chronic osteomyelitis caused by multi-resistant Gram-negative bacteria: evaluation of treatment with newer quinolones after prolonged follow-up. J Antimicrob Chemother (1997) 1.05
Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics (1998) 1.04
Influence of population density on antibiotic resistance. J Antimicrob Chemother (2003) 1.04
Mycoplasma pneumoniae-associated myelitis: a comprehensive review. Eur J Neurol (2006) 1.04
Use of intravenous ciprofloxacin in difficult-to-treat infections. Am J Med (1987) 1.04
Effects of slime produced by clinical isolates of coagulase-negative staphylococci on activities of various antimicrobial agents. Antimicrob Agents Chemother (1998) 1.04
Endemic Kaposi's sarcoma in human immunodeficiency virus type 1-seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions. J Invest Dermatol (1990) 1.03
Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome? Psychol Med (2009) 1.03
Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol (2007) 1.02
Prevalence study of different hepatitis markers among pregnant Albanian refugees in Greece. Eur J Epidemiol (1996) 1.02
A comparison of hepatitis B seroepidemiology in ten European countries. Epidemiol Infect (2008) 1.02
Efficacy of cinoxacin in urinary tract infections. Antimicrob Agents Chemother (1976) 1.01
Nosocomial vs. community-acquired infective endocarditis in Greece: changing epidemiological profile and mortality risk. Clin Microbiol Infect (2007) 1.00
Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study. Oncology (1998) 1.00
In-vitro activity of meropenem, a new carbapenem, against multiresistant Pseudomonas aeruginosa compared with that of other antipseudomonal antimicrobials. J Antimicrob Chemother (1989) 0.99
Prevalence of 16S rRNA methylase genes in Enterobacteriaceae isolates from a Greek university hospital. Clin Microbiol Infect (2012) 0.99
Evaluation of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections. Eur J Clin Microbiol (1986) 0.99
Poor efficacy of teicoplanin in treatment of deep-seated staphylococcal infections. Eur J Clin Microbiol Infect Dis (1988) 0.98
Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments. J Viral Hepat (2005) 0.98
Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection. J Infect Dis (2001) 0.98
Treatment with metronidazole of 48 patients with serious anaerobic infections. J Antimicrob Chemother (1977) 0.98
Cefuroxime: antimicrobial activity, human pharmacokinetics and therapeutic efficacy. J Antimicrob Chemother (1977) 0.98
Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis. J Hepatol (1995) 0.98
Does soluble triggering receptor expressed on myeloid cells-1 play any role in the pathogenesis of septic shock? Clin Exp Immunol (2005) 0.97
Ciprofloxacin interactions with imipenem and amikacin against multiresistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1987) 0.97
An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa. Br J Dermatol (2007) 0.97
Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections. Eur J Clin Microbiol (1983) 0.97
Passive smoking and chronic obstructive lung disease. Lancet (1987) 0.97
Stimulation of innate immunity by susceptible and multidrug-resistant Pseudomonas aeruginosa: an in vitro and in vivo study. Clin Exp Immunol (2004) 0.97
HIV epidemiology in Greece. Future Microbiol (2008) 0.96
Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis. Psychol Med (2010) 0.96
Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis. Antimicrob Agents Chemother (1995) 0.96
Low-dose IFN-alpha monotherapy in treatment-naive individuals with HIV-1 infection: evidence of potent suppression of viral replication. J Interferon Cytokine Res (2001) 0.96